Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| Yesterday 7:00 PM View:  | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 01-May-24 | Sale (Planned) | 15,000 | $110.92 | $1,663,850.00 | (< 1%) 11.71M to 11.69M | |
| 26-Apr-24 7:00 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 24-Apr-24 | Sale (Planned) | 15,000 | $108.32 | $1,624,840.00 | (< 1%) 11.72M to 11.71M | |
| 19-Apr-24 7:00 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 17-Apr-24 | Sale (Planned) | 15,000 | $103.38 | $1,550,700.00 | (< 1%) 11.74M to 11.72M | |
| 16-Apr-24 4:23 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 15-Apr-24 | Sale (Planned) | 15,000 | $105.02 | $1,575,300.00 | (< 1%) 1.66M to 1.64M | |
| 12-Apr-24 7:00 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 10-Apr-24 | Sale (Planned) | 15,000 | $107.12 | $1,606,860.00 | (< 1%) 11.75M to 11.74M | |
| 09-Apr-24 4:09 PM View: | Mock James M Chief Financial Officer | Moderna, Inc. (MRNA) | 08-Apr-24 | Option Sale | 705 | $101.93 | $71,859.30 | (12%) 5.75K to 5.05K | |
| 09-Apr-24 4:09 PM View: | Mock James M Chief Financial Officer | Moderna, Inc. (MRNA) | 05-Apr-24 | Option Exercise | 1,453 | -- | -- | 34% 4.3K to 5.75K | |
| 05-Apr-24 7:00 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 03-Apr-24 | Sale (Planned) | 15,000 | $101.68 | $1,525,270.00 | (< 1%) 11.77M to 11.75M | |
| 29-Mar-24 7:00 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 27-Mar-24 | Sale (Planned) | 15,000 | $109.06 | $1,635,860.00 | (< 1%) 11.78M to 11.77M | |
| 22-Mar-24 7:00 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 20-Mar-24 | Sale (Planned) | 15,000 | $102.39 | $1,535,820.00 | (< 1%) 11.8M to 11.78M | |
| 19-Mar-24 4:39 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 15-Mar-24 | Sale (Planned) | 15,000 | $103.17 | $1,547,550.00 | (< 1%) 1.67M to 1.66M | |
| 15-Mar-24 7:00 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 13-Mar-24 | Sale (Planned) | 15,000 | $108.54 | $1,628,030.00 | (< 1%) 11.81M to 11.8M | |
| 11-Mar-24 9:05 AM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 08-Mar-24 | Option Sale | 544 | $99.05 | $53,883.70 | (6%) 9.81K to 9.27K | |
| 11-Mar-24 9:05 AM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 07-Mar-24 | Option Exercise | 1,138 | -- | -- | 13% 8.67K to 9.81K | |
| 05-Mar-24 5:56 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 04-Mar-24 | Option Sale | 117 | $94.34 | $11,037.60 | (1%) 8.79K to 8.67K | |
| 05-Mar-24 5:52 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 04-Mar-24 | Option Sale | 309 | $94.34 | $29,150.50 | (< 1%) 1.67M to 1.67M | |
| 05-Mar-24 5:56 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 01-Mar-24 | Option Exercise | 233 | -- | -- | 3% 8.56K to 8.79K | |
| 05-Mar-24 5:52 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 01-Mar-24 | Option Exercise | 652 | -- | -- | < 1% 1.67M to 1.67M | |
| 01-Mar-24 5:25 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 29-Feb-24 | Option Sale | 2,388 | $94.57 | $225,838.00 | (< 1%) 1.67M to 1.67M | |
| 01-Mar-24 5:33 PM View: | Mock James M Chief Financial Officer | Moderna, Inc. (MRNA) | 29-Feb-24 | Option Sale | 647 | $94.57 | $61,188.10 | (13%) 4.95K to 4.3K | |
| 01-Mar-24 5:29 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 29-Feb-24 | Option Sale | 670 | $94.57 | $63,363.20 | (7%) 9.23K to 8.56K | |
| 01-Mar-24 5:33 PM View: | Mock James M Chief Financial Officer | Moderna, Inc. (MRNA) | 28-Feb-24 | Option Exercise | 1,315 | -- | -- | 36% 3.63K to 4.95K | |
| 01-Mar-24 5:25 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 28-Feb-24 | Option Exercise | 4,853 | -- | -- | < 1% 1.67M to 1.67M | |
| 01-Mar-24 5:29 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 28-Feb-24 | Option Exercise | 1,315 | -- | -- | 17% 7.91K to 9.23K | |
| 23-Feb-24 4:04 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 22-Feb-24 | Sale (Planned) | 15,000 | $100.00 | $1,500,000.00 | (< 1%) 1.68M to 1.67M | |
| 16-Feb-24 4:19 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 16-Feb-24 | Sale | 10,542 | $88.88 | $936,981.00 | (< 1%) 1.7M to 1.68M | |
| 16-Feb-24 4:10 PM View: | Bancel Stephane Chief Executive Officer Director | Moderna, Inc. (MRNA) | 16-Feb-24 | Sale | 26,351 | $88.88 | $2,342,100.00 | (< 1%) 21.1M to 21.08M | |
| 16-Feb-24 4:10 PM View: | Bancel Stephane Chief Executive Officer Director | Moderna, Inc. (MRNA) | 14-Feb-24 | Grant | 56,736 | -- | -- | < 1% 21.05M to 21.1M | |
| 16-Feb-24 4:19 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 14-Feb-24 | Grant | 22,694 | -- | -- | 1% 1.67M to 1.7M | |
| 13-Feb-24 4:13 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 12-Feb-24 | Option Sale | 304 | $86.23 | $26,213.70 | (< 1%) 1.67M to 1.67M | |
| 13-Feb-24 4:13 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 09-Feb-24 | Option Exercise | 522 | -- | -- | < 1% 1.67M to 1.67M | |
| 17-Jan-24 4:12 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 16-Jan-24 | Sale (Planned) | 15,000 | $103.90 | $1,558,500.00 | (< 1%) 1.69M to 1.67M | |
| 09-Jan-24 4:08 PM View: | Mock James M Chief Financial Officer | Moderna, Inc. (MRNA) | 08-Jan-24 | Option Sale | 772 | $109.75 | $84,730.60 | (18%) 4.4K to 3.63K | |
| 09-Jan-24 4:08 PM View: | Mock James M Chief Financial Officer | Moderna, Inc. (MRNA) | 05-Jan-24 | Option Exercise | 1,452 | -- | -- | 49% 2.95K to 4.4K | |
| 28-Dec-23 8:00 AM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 27-Dec-23 | Sale (Planned) | 45,000 | $100.01 | $4,500,450.00 | (3%) 1.73M to 1.69M | |
| 11-Dec-23 4:03 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 08-Dec-23 | Option Sale | 563 | $79.09 | $44,525.10 | (7%) 8.47K to 7.91K | |
| 11-Dec-23 4:03 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 07-Dec-23 | Option Exercise | 1,139 | -- | -- | 16% 7.34K to 8.47K | |
| 07-Dec-23 4:21 PM View: | Garay Arpa Chief Commercial Officer | Moderna, Inc. (MRNA) | 06-Dec-23 | Option Sale | 564 | $78.34 | $44,182.00 | (13%) 4.25K to 3.69K | |
| 07-Dec-23 4:21 PM View: | Garay Arpa Chief Commercial Officer | Moderna, Inc. (MRNA) | 05-Dec-23 | Option Exercise | 1,141 | -- | -- | 37% 3.11K to 4.25K | |
| 05-Dec-23 4:07 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 04-Dec-23 | Option Sale | 309 | $79.31 | $24,507.80 | (< 1%) 1.73M to 1.73M | |
| 05-Dec-23 4:10 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 04-Dec-23 | Option Sale | 111 | $79.31 | $8,803.79 | (1%) 7.45K to 7.34K | |
| 05-Dec-23 4:10 PM View: | Klinger Shannon Thyme Chief Legal Officer | Moderna, Inc. (MRNA) | 01-Dec-23 | Option Exercise | 232 | -- | -- | 3% 7.21K to 7.45K | |
| 05-Dec-23 4:07 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 01-Dec-23 | Option Exercise | 651 | -- | -- | < 1% 1.73M to 1.73M | |
| 30-Nov-23 4:11 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 29-Nov-23 | Option Sale | 1,136 | $79.81 | $90,665.50 | (< 1%) 1.73M to 1.73M | |
| 30-Nov-23 4:11 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 28-Nov-23 | Option Exercise | 2,411 | -- | -- | < 1% 1.73M to 1.73M | |
| 13-Nov-23 4:02 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 10-Nov-23 | Option Sale | 263 | $68.76 | $18,083.90 | (< 1%) 1.73M to 1.73M | |
| 13-Nov-23 4:02 PM View: | Hoge Stephen President | Moderna, Inc. (MRNA) | 09-Nov-23 | Option Exercise | 522 | -- | -- | < 1% 1.73M to 1.73M | |
| 03-Nov-23 7:00 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 01-Nov-23 | Sale (Planned) | 10,000 | $76.00 | $760,032.00 | (< 1%) 11.82M to 11.81M | |
| 27-Oct-23 7:00 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 25-Oct-23 | Sale (Planned) | 10,000 | $76.99 | $769,854.00 | (< 1%) 11.83M to 11.82M | |
| 13-Oct-23 7:00 PM View: | Afeyan Noubar Director | Moderna, Inc. (MRNA) | 11-Oct-23 | Sale (Planned) | 15,000 | $103.30 | $1,549,440.00 | (< 1%) 11.85M to 11.83M |
